One third of Delhi's population has antibodies against COVID-19 as per recent sero survey

▴ one-third-developed-coronavirus-antibodies-delhi-herd-immunity-at-40-percent
Antibodies in 40% of the population results in herd immunity

Nearly a third of Delhi's population has antibodies against Covid-19. Delhi’s Health Minister Satyendar Jain informed this today in a press briefing sharing the details of the sero survey conducted in the National Capital.

Mr. Jain informed that 29.1 per cent prevalence of COVID-19 antibodies have been found in the latest survey. He said, the highest prevalence was found in the southeast district. The State Health Minister asserted that as per Scientists, herd immunity is said to have developed in the community only when the antibody prevalence reaches at least up to 40 per cent of the population. He urged citizens to continue taking all necessary precautions in light of the ongoing pandemic.

The sero survey was conducted in the first week of August. The other two rounds of the survey are scheduled in the first weeks of September and October.

Meanwhile, the recovery rate of COVID-19 patients continues its upward streak and has reached around 74 per cent today. With sustained, pre-emptive and timely interventions by the government nearly 21 lakh people in the country have successfully recovered from COVID-19. India registered nearly 59000 recoveries in the last 24 hours and so far, a total of 20 lakh 96 thousand 664 people have recovered in the country.

The case fatality rate continues to show steady decline and now stands at 1.90 per cent. Nearly 30 States and Union Territories in the country have even lower fatality rates than the national average.

The Health Ministry said that around 69 thousand new cases of Covid-19 have been registered in the country in the last 24 hours taking the total number of cases to 28 lakh 36 thousand 926. Presently, the total number of active corona cases in the country is 6 lakh 86 thousand 395. In a single day, 977 deaths have also been reported taking the toll to 53866.

India is continuously stepping up it's COVID testing capacity. In the last 24 hours, the country moved closer to testing record one million samples in a day. With testing more than 9 lakh samples in a day, the nation achieved another milestone today. The positivity rate continues to decline despite increased testing and stands at around 7.5 per cent of the total samples tested.

The Union Health Ministry informed that the remarkable feat has been achieved by rigorously following the “Test, Track and Treat” strategy. It said, early identification through Testing, Surveillance and contact tracing along with focus on timely and appropriate clinical treatment of COVID-19 patients has ensured that only a small proportion of active cases require ventilator support.

The week-wise average daily tests witnessed a sharp increase from around 2.3 lakh in the first week of July 2020 to over 8 lakh in the current week.

With 9 lakh 18 thousand 470 tests yesterday, the cumulative COVID sample tests done so far in the country have further risen to reach 3 crore 26 lakhs 61 thousand 252 tests.

Government said that the strong determinant of this milestone has been a sustained expansion of testing labs across the country. From merely one lab in January this year, the country today has 1494 labs. Out of these 977 are government labs while the remaining 517 are private labs.

Tags : #DelhiCoronavirusNewsAug20 #CoronavirusAntibody #HerdCommunity #DelhiSeroSurvey #DelhiSeroSurveyResult #IndiaRecoveryRate #LatestCovidNewsAug20 #LatestCovidUpdateAug20

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Surviving Against the Odds: Steven Spinale's Journey After an Ingrown Hair Turns DeadlyMarch 29, 2024
10 reasons why media research and Planning are essential in Healthcare marketingMarch 29, 2024
The Surprising Link Between Sleep and Age Perception: What You Need to KnowMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 StudyMarch 29, 2024
Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024